Anjali Gowripalan
@agrowlipowli.bsky.social
44 followers 70 following 8 posts
Research Fellow @ ANU, Canberra 🇦🇺 | Viruses and Immunity Group | Interested in creative poxvirus engineering to produce novel therapeutics
Posts Media Videos Starter Packs
Reposted by Anjali Gowripalan
Reposted by Anjali Gowripalan
dctscharke.bsky.social
A great story showcasing the brilliant Yi Ning Fu, who I had the privilege of supervising last year as a student with the equally fantastic @agrowlipowli.bsky.social. It's a huge pleasure scienceing with them.
Reposted by Anjali Gowripalan
nature.com
Nature @nature.com · Mar 25
📸 Join Nature’s photo competition for a chance to be featured in the magazine, win a print and online subscription to the journal, and take home £500

Submit your best #ScientistAtWork photo to [email protected]. Entries close on Friday!
agrowlipowli.bsky.social
The first rule of virus making:

All you need is one,

but two is better.
agrowlipowli.bsky.social
Super cool example of viral trickery for oncolytic therapy
Reposted by Anjali Gowripalan
natbiotech.nature.com
Implementation of intellectual property education in academic institutions can result in increased opportunities for protecting IP and limit costs, but to be successful technology transfer offices must also adapt go.nature.com/4iCtdhc
rdcu.be/d3sq8
Reposted by Anjali Gowripalan
grovearmada.bsky.social
🎁 Early Xmas present from your friends at the MRC-University of Glasgow Centre for Virus Research @cvrinfo.bsky.social

We're thrilled to unwrap Viro3D - a comprehensive database of virus protein structures: >85,000 predicted structures from 4,400 human & animal viruses! 🦠

viro3d.cvr.gla.ac.uk
Viro3D
viro3d.cvr.gla.ac.uk
Reposted by Anjali Gowripalan
science.org
Science’s 2024 Breakthrough of the Year is lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months.

Learn more about this year's #BOTY and other big advances in science: scim.ag/3BrCtUn
Science’s 2024 Breakthrough of the Year is lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months. The drug attaches to the lattice-like capsid proteins that shield the virus’s genetic material—a mechanism that could inspire other antivirals. Lenacapavir could help end the HIV/AIDS epidemic, but that will hinge on access for those who need it most.
Reposted by Anjali Gowripalan
duckswabber.bsky.social
First case of HPAI H7N6 in New Zealand poultry. First HPAI ever reported in NZ, unrelated to AUS H7 outbreaks
👉https://www.reuters.com/world/asia-pacific/new-zealand-reports-first-case-h7-bird-flu-2024-12-02/#:~:text=Tests%20showed%20a%20rural%20chicken,raised%20fears%20of%20human%20transmission
agrowlipowli.bsky.social
So very grateful for the opportunity to present at #AVS12 among amazing company. Looking forward to the next one.
ausvirologysoc.bsky.social
Next up is Anjali Gowripalan
Who is Using oncolytic viruses to save Tasmanian devils from transmissible facial tumours. A crushing disease for such a charismatic species. #AVS12
Reposted by Anjali Gowripalan
ausvirologysoc.bsky.social
AVS is now on bluesky - just in time for our biennial meeting starting today #AVS12